Filter Results
:
(591)
Show Results For
-
All HBS Web
(591)
- News (35)
- Research (427)
- Multimedia (1)
- Faculty Publications (330)
Show Results For
-
All HBS Web
(591)
- News (35)
- Research (427)
- Multimedia (1)
- Faculty Publications (330)
- 30 Oct 2006
- First Look
First Look: October 31, 2006
contingent claims analysis (CCA). We illustrate how to use the CCA approach to model and measure sectoral and national risk exposures, and analyze policies to offset their potentially harmful effects. This new framework provides economic balance sheets for inter-linked...
View Details
Keywords:
Sean Silverthorne
- May 1998 (Revised April 2000)
- Case
City of New York, The
By: Paul M. Healy
This case examines the economics of a municipality, and then explores its financial position from the perspective of a bond rating firm.
View Details
Keywords:
Bonds;
Financial Management;
Public Sector;
City;
Financial Statements;
Government Administration
Healy, Paul M. "City of New York, The." Harvard Business School Case 198-030, May 1998. (Revised April 2000.)
- September 2010 (Revised August 2011)
- Case
Enman Oil, Inc. (A)
By: David F. Hawkins
Company pursues ways to reduce its debt-to-equity ratio by resorting to off-balance sheet debt transactions.
View Details
Keywords:
Financial Statements;
Borrowing and Debt;
Equity;
Financial Condition;
Financing and Loans;
United States
Hawkins, David F. "Enman Oil, Inc. (A)." Harvard Business School Case 111-042, September 2010. (Revised August 2011.)
- 09 Sep 2009
- First Look
First Look: September 9
foundation for understanding the use of and accounting for more complex derivatives. Specific issues raised include (1) the financial statement impact of hedge accounting; (2) motivations for using...
View Details
Keywords:
Martha Lagace
- Web
Consolidated Balance Sheet - Annual Report 2019
4,821 m. * In pursuit of greater comparability across the Harvard schools, the University has asked all the schools to report their net results in accordance with generally accepted accounting principles (GAAP) in the United States. In...
View Details
- October 2019
- Case
Impax Laboratories: Executing Accretive Acquisitions (A)
By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the...
View Details
Keywords:
Financial Reporting;
Financial Statements;
Mergers and Acquisitions;
Capital Structure;
Competition;
Competitive Advantage;
Corporate Strategy;
Pharmaceutical Industry;
United States
Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (A)." Harvard Business School Case 220-030, October 2019.
- Web
Consolidated Balance Sheet - Annual Report 2017
4,587 m. * In pursuit of greater comparability across the Harvard schools, the University has asked all the schools to report their net results in accordance with generally accepted accounting principles (GAAP) in the United States. In...
View Details
- 14 Nov 2007
- First Look
First Look: November 14, 2007
on the Market's Valuation of R&D Capital Author:Michael D. Kimbrough Periodical:The Accounting Review 82, no. 5 (October 2007): 1195-1225 Abstract Statement of Financial View Details
Keywords:
Martha Lagace
- Web
Consolidated Balance Sheet - Financial Report 2018
4,508 m. * In pursuit of greater comparability across the Harvard schools, the University has asked all the schools to report their net results in accordance with generally accepted accounting principles (GAAP) in the United States. In...
View Details
- Web
4.6 HBS Campus Demonstration Policy - MBA
University Identification Cards Policy 4.5 University-Wide Statement on Rights and Responsibilities 4.6 HBS Campus Demonstration Policy 5. Technology, Copyright, & Publishing Policies 6. Important Contact Information This policy outlines...
View Details
- 08 Oct 2010
- What Do You Think?
Will Transparency in CEO Compensation Have Unintended Consequences?
system?" Ajay Kumar Gupta put it this way: "I believe revealing compensation ratio(s) will help inculcate values, honesty, and accountability in the organization." Others were less sanguine. Zach Allen described it as a...
View Details
Keywords:
by Jim Heskett
- April 1998 (Revised June 1999)
- Case
Bausch & Lomb, Inc.: Pressure to Perform
By: Robert L. Simons, Alex C. Sapir '97 and Indra Reinbergs
Bausch & Lomb is the subject of press attacks and experiences a sharp fall in stock price when management practices are exposed. Aggressive goal setting, supported by financial market expectations, is discussed as a precursor to a series of events that results in...
View Details
Keywords:
Performance Expectations;
Management Practices and Processes;
Ethics;
Financial Markets;
Financial Statements;
Business and Shareholder Relations
Simons, Robert L., Alex C. Sapir '97, and Indra Reinbergs. "Bausch & Lomb, Inc.: Pressure to Perform." Harvard Business School Case 198-009, April 1998. (Revised June 1999.)
- October 1996 (Revised February 1997)
- Case
Upjohn Company, The: The Upjohn-Pharmacia Merger
By: Krishna G. Palepu and Amy P. Hutton
In August 1995, the Upjohn Co. and Pharmacia AB announced a "merger of equals." This case provides background information on the industry, the position of Upjohn, and Upjohn's rationale for the proposed merger.
View Details
Keywords:
Mergers and Acquisitions;
Financial Statements;
Business Strategy;
Annual Reports;
Pharmaceutical Industry
Palepu, Krishna G., and Amy P. Hutton. "Upjohn Company, The: The Upjohn-Pharmacia Merger." Harvard Business School Case 197-034, October 1996. (Revised February 1997.)
- August 2009 (Revised August 2010)
- Supplement
Eddie Bauer (B)
By: Paul M. Healy, Sharon P. Katz and Aldo Sesia
In February 2007, shareholders of Eddie Bauer, the specialty apparel retailer, were scheduled to vote on management's proposed sale of the company to two private equity firms. More than 50% of outstanding shares in Eddie Bauer needed to be voted in favor of the deal...
View Details
Keywords:
Financial Statements;
Mergers and Acquisitions;
Governing and Advisory Boards;
Privatization;
Valuation;
Apparel and Accessories Industry;
Retail Industry;
United States
Healy, Paul M., Sharon P. Katz, and Aldo Sesia. "Eddie Bauer (B)." Harvard Business School Supplement 110-009, August 2009. (Revised August 2010.)
- Web
2021 Symposium - Race, Gender & Equity
strikingly come to the fore this past year, here in the US and across the world. We have been alternately devastated and heartened by what we’ve seen: civil protests over the repeated, now increasingly publicized police killings of Black people, as well as View Details
- October 2019
- Supplement
Impax Laboratories: Executing Accretive Acquisitions (B)
By: Benjamin C. Esty and Daniel Fisher
Explores events after Impax announced the acquisition of a portfolio of generic pharmaceutical products from Teva in June 2016.
View Details
Keywords:
Financial Reporting;
Financial Statements;
Mergers and Acquisitions;
Capital Structure;
Financial Strategy;
Competition;
Competitive Advantage;
Corporate Strategy;
Pharmaceutical Industry;
United States
Esty, Benjamin C., and Daniel Fisher. "Impax Laboratories: Executing Accretive Acquisitions (B)." Harvard Business School Supplement 220-031, October 2019.
- Web
1.1 HBS Community Values - MBA
Statement The mission of Harvard Business School is to educate leaders who make a difference in the world. Achieving this mission requires an environment of trust and mutual respect, free expression and inquiry, and a commitment to truth,...
View Details
- Web
Supplemental Financial Information - Financial Report 2015
Financials Supplemental Financial Information Statement of Activity & Cash Flows Consolidated Balance Sheet Supplemental Financial Information page 2 of 2 Expenses The School’s total operating expenses for fiscal 2015 were $660 million,...
View Details
- Web
Supplemental Financial Information - Annual Report 2016
with generally accepted accounting principles (GAAP) in the United States. In addition to results for fiscal 2016, the School’s results for fiscal years 2014 and 2015 are presented in accordance with GAAP within the View Details
- October 2019
- Supplement
Impax Laboratories: Executing Accretive Transactions (A)
By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the...
View Details